CONTACT US   |  (864) 397-5101

Feb. 15 – 19 Named South Carolina Life Sciences Week

South Carolina Gov. Henry McMaster

Proclamation – Feb. 15, 2021

WHEREAS, South Carolina has cultivated a cutting-edge life sciences sector with an annual economic impact of more than $12 billion dollars; and

WHEREAS, more than 800 firms and over 43,000 professionals are directly involved in the research, development and commercialization of innovative healthcare, medical device, industrial, environmental and agricultural biotechnology products; and

WHEREAS, since 2017, the life sciences sector has become South Carolina’s fastest- growing industry, with employment growing at double the rate of South Carolina’s economy as a whole; and

WHEREAS, SCbio is the organization exclusively focused on attracting new life science sector jobs and investment to South Carolina; and

WHEREAS, during the COVID-19 pandemic, more than 100 life sciences organizations across South Carolina worked together to support and promote the procurement and distribution of personal protective equipment, support and implement COVID-19 testing and expedite health solutions for our citizens; and

WHEREAS, in collaboration with the South Carolina Department of Commerce and SCbio, South Carolina’s economic development recruitment efforts shall include an enhanced emphasis and focus on attracting, building, advancing, innovating and growing existing and new life sciences businesses in the state.

NOW, THEREFORE, I, Henry McMaster, Governor of the great State of South Carolina, do hereby proclaim February 15-19, 2021, as

SCbio LIFE SCIENCE WEEK

throughout the state and encourage all South Carolinians to recognize and appreciate the many contributions of the life sciences industry to South Carolina’s health and economic prosperity.

Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more

Tamia Sumpter

Tamia is a driven senior undergraduate Bioengineering student currently enrolled at Clemson University. With a strong foundation in her field, she has honed her skills through hands-on experience in research and development at Eli Lilly & Company. During her time in the ADME department, Tamia contributed significantly by working on siRNAs and their applications in finding In Vitro-In Vivo Correlation (IVIVC). Looking ahead, Tamia has set her sights on a promising career in law. She aspires to specialize in Intellectual Property Law, with a particular focus on serving as in-house counsel for leading medical device or pharmaceutical companies. Her enthusiasm for this role is palpable as she prepares to embark on her legal journey! She is also a proud member of the Omicron Phi chapter of Delta Sigma Theta Sorority, Inc., PEER Mentor for Clemson PEER/WiSE, and currently serves as the President of Clemson Bioengineering Organization (CBO). With her unique blend of scientific knowledge and legal interests, Tamia is poised to make a meaningful impact in the healthcare and life sciences industries.